{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:21:05Z","timestamp":1761920465277},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10384-018-0607-4","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T06:28:33Z","timestamp":1531290513000},"page":"598-604","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis"],"prefix":"10.1007","volume":"62","author":[{"name":"Siriraj Neuroimmunology Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattapong","family":"Mekhasingharak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niphon","family":"Chirapapaisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poramaet","family":"Laowanapiban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasitorn","family":"Siritho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naraporn","family":"Prayoonwiwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanjira","family":"Satukijchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiraporn","family":"Jitprapaikulsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornsawan","family":"Mekhasingharak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"607_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389.","journal-title":"Neurology."},{"key":"607_CR2","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","volume":"124","author":"N Evangelou","year":"2001","unstructured":"Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124:1813\u201320.","journal-title":"Brain."},{"key":"607_CR3","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.3928\/15428877-20101031-01","volume":"41","author":"AA Aref","year":"2010","unstructured":"Aref AA, Budenz DL. Spectral domain optical coherence tomography in the diagnosis and management of glaucoma. Ophthalmic Surg Lasers Imaging. 2010;41:S15\u201327.","journal-title":"Ophthalmic Surg Lasers Imaging."},{"key":"607_CR4","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1167\/iovs.10-5222","volume":"51","author":"JC Mwanza","year":"2010","unstructured":"Mwanza JC, Chang RT, Budenz DL, Durbin MK, Gendy MG, Shi W, et al. Reproducibility of peripapillary retinal nerve fiber layer thickness and optic nerve head parameters measured with cirrus HD-OCT in glaucomatous eyes. Investig Ophthalmol Vis Sci. 2010;51:5724\u201330.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"607_CR5","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s00417-016-3408-9","volume":"254","author":"M Fukuchi","year":"2016","unstructured":"Fukuchi M, Kishi S, Li D, Akiyama H. Acute ganglion cell loss during rapid visual recovery in optic neuritis. Graefes Arch Clin Exp Ophthalmol. 2016;254:2355\u201360.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"607_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/0301-4738.121071","volume":"61","author":"R Saxena","year":"2013","unstructured":"Saxena R, Bandyopadhyay G, Singh D, Singh S, Sharma P, Menon V. Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis. Indian J Ophthalmol. 2013;61:562\u20136.","journal-title":"Indian J Ophthalmol."},{"key":"607_CR7","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106\u201312.","journal-title":"Lancet."},{"key":"607_CR8","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology. 2007;69:2221\u201331.","journal-title":"Neurology."},{"key":"607_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130:1194\u2013205.","journal-title":"Brain."},{"key":"607_CR10","first-page":"672931","volume":"2015","author":"H Yang","year":"2015","unstructured":"Yang H, Qiu W, Zhao X, Xiao W, Lin S, Luo Y, et al. The correlation between aquaporin-4 antibody and the visual function of patients with demyelinating optic neuritis at onset. J Ophthalmol. 2015;2015:672931.","journal-title":"J Ophthalmol."},{"key":"607_CR11","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008;70:2197\u2013200.","journal-title":"Neurology."},{"key":"607_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol."},{"key":"607_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247:137\u201342.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"607_CR14","doi-asserted-by":"publisher","first-page":"e0171880","DOI":"10.1371\/journal.pone.0171880","volume":"12","author":"Y Matsumoto","year":"2017","unstructured":"Matsumoto Y, Mori S, Ueda K, Kurimoto T, Kanamori A, Yamada Y, et al. Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure\u2013function associations in Japanese patients with optic neuritis. PloS One. 2017;12:e0171880.","journal-title":"PloS One."},{"key":"607_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000453318","volume":"57","author":"MP Bambo","year":"2017","unstructured":"Bambo MP, Guerri N, Ferrandez B, Cameo B, Fuertes I, Polo V, et al. Evaluation of the macular ganglion cell-inner plexiform layer and the circumpapillary retinal nerve fiber layer in early to severe stages of glaucoma: correlation with central visual function and visual field indexes. Ophthalmic Res. 2017;57:216\u201323.","journal-title":"Ophthalmic Res."},{"key":"607_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jfo.2016.08.004","volume":"40","author":"M Zeitoun","year":"2017","unstructured":"Zeitoun M. \u201cPoint by point\u201d approach to structure\u2013function correlation of glaucoma on the ganglion cell complex in the posterior pole (in French). J Fr Ophtalmol. 2017;40:44\u201360.","journal-title":"J Fr Ophtalmol"},{"key":"607_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1515\/folmed-2016-0027","volume":"58","author":"SS Kostianeva","year":"2016","unstructured":"Kostianeva SS, Konareva-Kostianeva MI, Atanassov MA. Relationship between visual field changes and optical coherence tomography measurements in advanced open-angle glaucoma. Folia Med (Plovdiv). 2016;58:174\u201381.","journal-title":"Folia Med (Plovdiv)."},{"key":"607_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9:921\u201332.","journal-title":"Lancet Neurol."},{"key":"607_CR19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458515578888","volume":"21","author":"O Outteryck","year":"2015","unstructured":"Outteryck O, Majed B, Defoort-Dhellemmes S, Vermersch P, Zephir H. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis. Mult Scler. 2015;21:1781\u201393.","journal-title":"Mult Scler."},{"key":"607_CR20","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00417-010-1344-7","volume":"248","author":"M Nakamura","year":"2010","unstructured":"Nakamura M, Nakazawa T, Doi H, Hariya T, Omodaka K, Misu T, et al. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol. 2010;248:1777\u201385.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"607_CR21","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1167\/iovs.08-1815","volume":"49","author":"H Merle","year":"2008","unstructured":"Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Investig Ophthalmol Vis Sci. 2008;49:4412\u20137.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"607_CR22","volume-title":"Clinical decisions in glaucoma","author":"E Hodapp","year":"1993","unstructured":"Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis: Mosby; 1993."},{"key":"607_CR23","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1167\/iovs.05-0490","volume":"46","author":"CK Leung","year":"2005","unstructured":"Leung CK, Chong KK, Chan WM, Yiu CK, Tso MY, Woo J, et al. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure\/function regression analysis in glaucoma. Investig Ophthalmol Vis Sci. 2005;46:3702\u201311.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"607_CR24","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1167\/iovs.09-5053","volume":"51","author":"NR Kim","year":"2010","unstructured":"Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim CY. Structure\u2013function relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci. 2010;51:4646\u201351.","journal-title":"Invest Ophthalmol Vis Sci."}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-018-0607-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-018-0607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-018-0607-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T23:20:21Z","timestamp":1562800821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-018-0607-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["607"],"URL":"https:\/\/doi.org\/10.1007\/s10384-018-0607-4","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"type":"print","value":"0021-5155"},{"type":"electronic","value":"1613-2246"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"19 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N. Mekhasingharak, None; N. Chirapapaisan, None; P. Laowanapiban, None; S. Siritho, Speaker fees (Biogen Idec, Menarini, Merck Serono, Novartis, Pacific Healthcare, UCB), Travel fees (Biogen Idec, Menarini, Merck Serono, Novartis, Pacific Healthcare, UCB); N. Prayoonwiwat, Speaker fees (Bayer Schering Pharma, Eisai, Novartis, Pfizer Pharmaceutical, Sanofi-Aventis), Travel fees (Bayer Schering Pharma, Eisai, Novartis, Pfizer Pharmaceutical, Sanofi-Aventis); C. Satukijchai, Travel fees (Biogen Idec, Merck Serono, Novartis, UCB); J. Jitprapaikulsan, None; P. Mekhasingharak, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}